Volume - 11, Issue - 1, Jan - March 2020
[ CLICK HERE ]
Volume - 11, Issue - 2, April - June 2020
[ CLICK HERE ]
Volume - 11, Issue - 3, July - September 2020
[ CLICK HERE ]
Volume - 11, Issue - 4, October - December 2020
[ CLICK HERE ]
Volume - 11, Special Issue-Abstracts-AICTE Sponsored Conference, 19- 08- 2020
[ CLICK HERE ]

 

Publication Ethics and malpractice statements

Journal of Global Trends in Pharmaceutical Sciences (JGTPS) advices the authors not to pay any agents who assure you for quick acceptance and publishing. JGTPS is not responsible for any cash transaction between the agents and authors. We have not authorized any person to act as agent. All correspondence should be made only to our official email ID: editorjgtps@gmail.com

All submitted papers are subjected to plagiarism check and peer-review; these processes may take some months. JGTPS will not charge any amount for quick or unethical publications. Other than article processing, publishing of article is free and open access. Ethical standards for publication exist to ensure high-quality scientific publications, public trust in scientific findings, and that people receive credit for their ideas. It is important to avoid:

Data fabrication and falsification

Data fabrication means the researcher did not actually do the study, but made up data. Data falsification means the researcher did the experiment, but then changed some of the data. Both of these practices make people distrust scientists. If the public is mistrustful of science then it will be less willing to provide funding support.

Plagiarism

Taking the ideas and work of others without giving them credit is unfair and dishonest. Copying even one sentence from someone else's manuscript, or even one of your own that has previously been published, without proper citation is considered plagiarism-use your own words instead.

Multiple submissions

It is unethical to submit the same manuscript to more than one journal at the same time. Doing this wastes the time of editors and peer reviewers, and can damage the reputation of journals if published in more than one.

Redundant publications

This means publishing many very similar manuscripts based on the same experiment. It can make readers less likely to pay attention to your manuscripts.

Improper author contribution or attribution:

All listed authors must have made a significant scientific contribution to the research in the manuscript and approved all its claims. Don't forget to list everyone who made a significant scientific contribution, including students and laboratory technicians.

COPE

Our journal will follow the guidelines of COPE (Committee on Publication Ethics) and also registered. It is concerned with the integrity of peer-reviewed publications in life science (Pharmaceutical Sciences).

Plagiarism detection

Plagiarism detection initiative by online sources. In cases of suspected plagiarism, our journals to detect instances of overlapping and similar text in submitted manuscripts.

Privacy Statement

The names and email addresses entered in this journal site will be used exclusively for the stated purposes of this journal and will not be made available for any other purpose or to any other party.

Policies on Conflict of Interest

Journal submissions are assigned to editors in an effort to minimize potential conflicts of interest. The following relationships between editors and authors are considered conflicts and are avoided: Current colleagues, recent colleagues, recent co-authors, and doctoral students for which editor served as committee chair. After papers are assigned, individual editors are required to inform the managing editor of any conflicts not included in the list above. In the event that none of the editors satisfy all of the conflict screens, co-editors who are least conflicted will be assigned to the manuscript. In addition, co-editors who are least conflicted are assigned for all paper submissions by sitting editors. Journal submissions are also assigned to referees to minimize conflicts of interest. After papers are assigned, referees are asked to inform the editor of any conflicts that may exist.

Human and Animal Rights

All research must have been carried out within an appropriate ethical framework. If there is suspicion that work has not taken place within an appropriate ethical framework, Editors will follow may reject the manuscript, and/or contact the author(s)’ ethics committee. On rare occasions, if the Editor has serious concerns about the ethics of a study, the manuscript may be rejected on ethical grounds, even if approval from an ethics committee has been obtained.

Research involving human subjects, human material, or human data, must have been performed in accordance with the Declaration of Helsinki and must have been approved by an appropriate ethics committee.

The submitted study has to be supported by the ethics/bioethics committee approval.

Authors reporting the use of a new procedure or tool in a clinical setting, for example as a technical advance or case report, must give a clear justification in the manuscript for why the new procedure or tool was deemed more appropriate than usual clinical practice to meet the patient’s clinical need. Such justification is not required if the new procedure is already approved for clinical use at the authors’ institution. Authors will be expected to have obtained ethics committee approval and informed patient consent for any experimental use of a novel procedure or tool where a clear clinical advantage based on clinical need was not apparent before treatment.

 

Role of Editors: The role of the editors is to evaluate the suitability of submitted manuscripts for the journal, including: (a) the quality of the manuscript, (b) whether it meets the Aims and Scope of the journal, and (c) the originality of the work. The editors will not disclose information about a submitted manuscript to anyone other than the corresponding author, reviewers or potential reviewers, or other members of the editorial board. Editors will ensure the prompt handling of the review process. Editors will evaluate the merit of manuscripts for intellectual content without regard to race, gender, country of origin, ethnicity, religion, or sexual orientation. Editors shall take reasonable steps to identify and prevent the publication of papers where research misconduct has occurred. In no case shall a journal or its editors encourage such misconduct, or knowingly allow such misconduct to take place. In the event that a journal’s editors are made aware of any allegation of research misconduct the publisher or editor shall deal with allegations appropriately. Editors should always be willing to publish corrections, clarifications, retractions and apologies when needed.

 

Role of Reviewers: Peer review is essential to the journal in assisting in making editorial decisions and assisting authors in manuscript improvement. Reviewers should point out relevant publications not cited in the manuscript and point out any similarities with previously published works. Reviewers should not consider manuscripts with conflicts of interest, competitive, financial, or collaborative. If a potential reviewer feels unqualified to review the manuscript, that reviewer should notify the editors immediately and decline the review. Manuscripts received for review will be treated as confidential documents and not shown or discussed with other without authorization from the editors. Authors should expect to receive reviewer reports in a prompt manner, normally within three weeks. Reviewer misconduct (breach of confidentiality, delay of peer review, plagiarism, or conflicts of interest) will not be tolerated.

 

Role of Authors: Authors of original research (not previously published or under consideration for publication elsewhere) should be an accurate presentation of the work carried out, a discussion of the significance of the work in context with previous works, and should contain sufficient experimental detail to allow others to replicate the work. Appropriate citation of previously published works must always be included. Authors should disclose any financial or other conflicts of interest that may be construed as influencing the data or interpretation. All sources of financial support should be disclosed. Authorship should be limited to those persons who have made a significant contribution to the work in terms of conception, design, experimental implementation, and data analysis and interpretation. All persons making significant contributions should be included as co-authors. If an author discovers a significant error in the published work, the author is obligated to inform the journal editor in order to either correct or retract the paper.

Informed Consent

Including of details, images related to individual participants are not allowed.

Any queries: editorjgtps@gmail.com

 

VIEW MORE